UnitedHealth stock rebounds after rout; Medicare Advantage rates set the next test
UnitedHealth shares rose 4% to $294.02 Wednesday, rebounding after a 19% plunge Tuesday triggered by a weak 2026 outlook and a Medicare Advantage payment proposal. The company reported fourth-quarter net earnings of $0.01 per share, including a $1.6 billion cyberattack charge. Investors await Washington’s final 2027 Medicare rate decision, due by April 6.